I. Boutron

Statistics and Probability · 2008–2021

A researcher in the Science corpus: 17 papers; trusts 7 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Statistics and Probability — 273 citations into it; #5,216 of 12,932 by trust here, #234 by citations
• General Health Professions — 128 citations into it
• Economics and Econometrics — 97 citations into it; #11,370 of 23,481 by trust here, #2,438 by citations
• Public Health, Environmental and Occupational Health — 50 citations into it
• History and Philosophy of Science — 22 citations into it

Whom I. Boutron trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. David Moher
2. Douglas G. Altman
3. K. F. Schulz
4. P. Glasziou
5. Matthew J. Page
6. A. Liberati
7. J. McKenzie
8. Peter M. Rothwell
9. Monya Baker
10. Tammy Hoffmann

Who trusts I. Boutron overall

1. K. F. Schulz
2. Douglas G. Altman
3. David Moher
4. Gunther Eysenbach
5. Susan Michie
6. Matthew J. Page
7. Covadonga Chaves
8. R. Agha
9. Y. Panteleeva
10. P. Millear

Papers from I. Boutron's perspective

Ordered by how strongly the researchers I. Boutron trusts endorse each paper. Same corpus, a different order for every researcher.

1. Reducing waste from incomplete or unusable reports of biomedical research. (The Lancet)
2. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (Medical Journal of Australia)
3. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (Annals of Internal Medicine)
4. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. (New England Journal of Medicine)
5. Systematic Review and Meta-analysis Supplements for Primary and Secondary Prevention: Mortality in Randomized Trials of Antioxidant
6. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide (British medical journal)
7. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. (New England Journal of Medicine)
8. 1,500 scientists lift the lid on reproducibility (Nature)
9. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review (Systematic Reviews)
10. External validity of randomised controlled trials: "to whom do the results of this trial apply?".

Their papers

• Reducing waste from incomplete or unusable reports of biomedical research. (2014) — 1,136 citations
• Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. (2008) — 2,305 citations
• Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide (2014) — 8,871 citations
• ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016) — 17,786 citations
• PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (2020) — 10,812 citations
• The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations (2015) — 6,672 citations
• Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. (2020) — 2,634 citations
• Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. (2010) — 736 citations
• CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. (2017) — 1,200 citations
• Comparison of registered and published primary outcomes in randomized controlled trials. (2009) — 691 citations
• RoB 2: a revised tool for assessing risk of bias in randomised trials (2019) — 28,662 citations
• The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2020) — 94,440 citations
• The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. (2021) — 3,176 citations
• The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021) — 25,061 citations
• A revised tool for assessing risk of bias in randomized trials (2016) — 1,588 citations
• No surgical innovation without evaluation: the IDEAL recommendations. (2009) — 1,710 citations
• Challenges in evaluating surgical innovation (2009) — 612 citations